Talis Biomedical Corp financial data

Symbol
TLIS on Nasdaq
Industry
Laboratory Analytical Instruments
Location
1100 Island Drive, Suite 101, Redwood City, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
SlipChip Corp (to 10/17/2017)
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 947 % -18.9%
Quick Ratio 13 %
Debt-to-equity 34.3 % +27.7%
Return On Equity -75.4 % -9.15%
Return On Assets -56.2 % -3.1%
Operating Margin -6.26K % -76%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 31.7M shares -44.1%
Common Stock, Shares, Outstanding 1.82M shares -93.2%
Entity Public Float 8.15B USD +11%
Common Stock, Value, Issued 0 USD -100%
Weighted Average Number of Shares Outstanding, Basic 1.82M shares +0.52%
Weighted Average Number of Shares Outstanding, Diluted 1.82M shares +0.52%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 989K USD -65.2%
Research and Development Expense 29.4M USD -54%
Costs and Expenses 62.9M USD -39.5%
Operating Income (Loss) -61.9M USD +38.8%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -57.2M USD +41.5%
Earnings Per Share, Basic -31.4 USD/shares +56%
Earnings Per Share, Diluted -31.4 USD/shares +56%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 70.3M USD -37.7%
Inventory, Net 2.03M USD
Assets, Current 71.2M USD -38.4%
Property, Plant and Equipment, Net 1.63M USD -55.2%
Operating Lease, Right-of-Use Asset 8.15M USD -33.6%
Other Assets, Noncurrent 1.54M USD 0%
Assets 82.5M USD -38%
Accounts Payable, Current 3.62M USD -6.51%
Accrued Liabilities, Current 992K USD -38.5%
Liabilities, Current 9.47M USD -15.3%
Operating Lease, Liability, Noncurrent 16.3M USD +39.1%
Liabilities 25.8M USD +12.6%
Retained Earnings (Accumulated Deficit) -553M USD -11.5%
Stockholders' Equity Attributable to Parent 56.7M USD -48.5%
Liabilities and Equity 82.5M USD -38%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.43M USD +61%
Net Cash Provided by (Used in) Financing Activities 2K USD -93.9%
Net Cash Provided by (Used in) Investing Activities 30K USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 1.82M shares -93.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -6.4M USD +61.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 71.9M USD -37.8%
Deferred Tax Assets, Valuation Allowance 161M USD +14.5%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 164M USD +11.2%
Operating Lease, Liability 19.2M USD +30.8%
Depreciation 6.6M USD +313%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 24.2M USD +31.6%
Property, Plant and Equipment, Gross 16M USD +5.44%
Operating Lease, Liability, Current 2.9M USD -2.03%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.14M USD +87.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.06M USD +18.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure -14.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.94M USD +34.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.24M USD +88.3%
Deferred Tax Assets, Operating Loss Carryforwards 81.7M USD +22.5%
Unrecognized Tax Benefits 10.3M USD +15.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.33M USD +89.3%
Operating Lease, Payments 3.97M USD +192%
Deferred Tax Assets, Net of Valuation Allowance 3.67M USD -50.9%
Share-based Payment Arrangement, Expense 3.77M USD -24.7%